In the past five years, the university has been awarded $6.2 million in eye research funding from various sources. Researchers include Douglas R. Lazzaro, MD, professor and chair of ophthalmology; William J. Brunken, PhD, professor of cell biology and ophthalmology and director of ophthalmic research; and John Danias, MD, PhD, professor of cell biology and ophthalmology. The team will research the role of the extracellular matrix in retinal development and disease and new treatment options for glaucoma.
Related Articles on Ophthalmology:
FDA Approves Carl Zeiss Meditec’s Cirrus HD-OCT for Dry AMD and Glaucoma
Dr. Paul Lee Appointed Director of the W.K. Kellogg Eye Center at University of Michigan
Florida Eye Institute to Offer New and Expanded Range of Lens Implants for Cataract Patients
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
